Navigation Links
ATS Medical Announces Third Quarter 2009 Results
Date:11/2/2009

ly malleable by hand. This combination of attributes makes the probe particularly useful in minimally invasive cardiac arrhythmia procedures.
  • The Company received CE Mark for the new ATS CryoMaze 10-S Probe in October. European launch of the 10-S Probe will begin in the fourth quarter.
  • "Our focused R&D investments continue to deliver new products that are specifically designed to meet the unique needs of our cardiac surgeon customers around the world," commented Mr. Dale. "We have confidence that we have the right portfolio of current and upcoming products to deliver continued growth and expand our market presence in all segments."

    2009 Guidance

    For the full year 2009 the Company re-affirmed its previous revenue guidance of $77 to $79 million. Additionally, the Company anticipates it may generate net income in the fourth quarter of 2009.

    Conference Call Today

    ATS management will host a conference call today, November 2, 2009, at 5:00 p.m. ET to discuss its 2009 third quarter financial results and current corporate developments. The dial-in number for the conference call is 866-700-0161 for domestic participants and 617-213-8832 for international participants with a passcode of 96839682. A live webcast of the call can also be accessed at www.atsmedical.com by clicking on the Investors icon.

    A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain available for seven days. The replay can be accessed by dialing 888-286-8010 for domestic participants and 617-801-6888 for international callers, using the passcode 52986153.

    Disclosure of Non-GAAP Financial Measures

    ATS reports its financial results in accordance with generally accepted accounting principles (GAAP). In addition, from time to time, we include other measu
    '/>"/>

    SOURCE ATS Medical, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
    3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    4. Globus Medical Raises $110 Million in Series E Financing Round
    5. Quark Pharmaceuticals Appoints New Chief Medical Officer
    6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
    7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
    8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
    9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
    10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
    11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2009)... Dec. 15 Cumberland Pharmaceuticals Inc. ... announced new top-line results for a patient preference ... Solution, a prescription laxative packaged as a crystalline ... ,, Kristalose is the only prescription-strength laxative available ... 50 patients with a recent diagnosis of chronic ...
    (Date:12/15/2009)... -- Today,s New York Times ... Drugs Spurs Division," illustrates an internal renal community ... continuing to be deprived of their life-saving immunosuppressive ... ,, As Congress is poised to approve this ... of transplant kidney recipients, behind-the-scenes debate continues within ...
    (Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Surgical ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The just released ... Instrument Manufacturing Industry report is the ...
    Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Many Women Miscalculate Time to Full Term Birth 61852 1Many Women Miscalculate Time to Full Term Birth 61852 2Many Women Miscalculate Time to Full Term Birth 61852 3Many Women Miscalculate Time to Full Term Birth 61852 4New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 1New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 2New Breast Cancer Recommendation May Cost Lives While Saving Money 61848 3California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 1California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 2California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 3California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pai 61844 4
    ... Dec. 18 Epeius Biotechnologies,Corporation announced today ... of,Product Registration for Rexin-G(R) from the Philippine ... commercialization of its lead product as a ... of intractable cancers.,Developed as a tumor-targeted anticancer ...
    ... Scimitar Equity Research, Inc. issues a,review on Nventa ... and Vaccine Candidate for the Treatment of,Diseases Caused ... is,available on Scimitar,s website: http://www.scimitarequity.com ., ... therapeutics for the treatment of viral,infections and cancer, ...
    Other Medicine Technology:ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3Initiation of Coverage Informational Review Issued by Scimitar Equity Research 2
    (Date:12/15/2009)... ANN ARBOR, Mich. A new study links chronic ... cells that act as sentinels to activate the body,s ... Veterans Affairs research adds to growing awareness of the ... disease that affects more than 12 million Americans with ... Understanding immune factors is key if doctors are to ...
    (Date:12/15/2009)... United Nations Foundation has led the fight against malaria, and ... 2009 that the global strategies for ending malaria deaths are working,” ... United Nations Foundation , ... Washington, D.C. (Vocus) December ... Foundation has led the fight against malaria, and I am ...
    (Date:12/15/2009)... changes increases risk in teens, study suggests , , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ... among those aged 12 and older the risk of ...
    (Date:12/15/2009)... RPS Worldwide Launches their Affiliate Program, a new employment opportunity for ... the simplest and easiest business opportunities in America today. , ... ... one of the nation,s most successful collection agencies, is spreading holiday ... after the season,s end. RPS has created an opportunity for ...
    (Date:12/15/2009)... decide benefits of imaging outweigh the risks , , TUESDAY, ... a serious risk to people with heart pacemakers, researchers ... pacemakers to a simulated MRI magnetic field and then ... the pacemaker lead, where it would touch the interior ... magnetic pulses caused certain pacemakers to deliver a drastically ...
    Breaking Medicine News(10 mins):Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2
    ... intervention is more effective than short-term vitamin E capsule therapy ... in the management of children with NAFLD. , ... Liang, is described in a research article to be published ... , NAFLD is likely to reach epidemic proportions in children ...
    ... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today announced ... NASDAQ Global Market closes on Wednesday, May,7, 2008. That ... and Robert E. Hoffman, Arena,s Vice President, Finance,and Chief ... p.m.,Eastern Time (2:00 p.m. Pacific Time) to discuss the ...
    ... Kitchen 6 Weeks to Summer(SM) to Help You Look and Feel ... ... Are you working towards a,healthier lifestyle? Looking for new recipes or ... Weeks to,Summer(SM) is designed to help you stay on track with your ...
    ... C. diff-associated disease (CDAD), otherwise known as severe ... diff) pathogen, has been the subject of heightened concern ... this month by the federal Agency for Healthcare Research ... fatal diarrheal infections in U.S. hospitals between 2000 and ...
    ... up 54.1%; Adjusted EPS down 9.9% Company Lowers ... , ... Glance, -- Reported EPS up 54.1 percent at $1.71 -- Adjusted ... repurchase program -- R.J. Reynolds continues to build total growth-brand share ...
    ... PARK, Fla., April 30 Nihon LocalSoft, ... for the purpose of supporting US,Medical Device ... support entering the Japanese market, recently helped ... translations,labeling, and localized embedded text for their ...
    Other Medicine News:Health News:How to manage Chinese obese children with non-alcoholic fatty liver disease? 2Health News:Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008 2Health News:Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008 3Health News:Keep Healthy Goals on Track This Summer 2Health News:Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence 2Health News:RAI CEO: 'Returning Value in a Challenging Time' 2Health News:RAI CEO: 'Returning Value in a Challenging Time' 3Health News:RAI CEO: 'Returning Value in a Challenging Time' 4Health News:RAI CEO: 'Returning Value in a Challenging Time' 5Health News:RAI CEO: 'Returning Value in a Challenging Time' 6Health News:RAI CEO: 'Returning Value in a Challenging Time' 7Health News:RAI CEO: 'Returning Value in a Challenging Time' 8Health News:RAI CEO: 'Returning Value in a Challenging Time' 9Health News:RAI CEO: 'Returning Value in a Challenging Time' 10Health News:RAI CEO: 'Returning Value in a Challenging Time' 11Health News:RAI CEO: 'Returning Value in a Challenging Time' 12Health News:RAI CEO: 'Returning Value in a Challenging Time' 13Health News:RAI CEO: 'Returning Value in a Challenging Time' 14Health News:RAI CEO: 'Returning Value in a Challenging Time' 15Health News:RAI CEO: 'Returning Value in a Challenging Time' 16Health News:RAI CEO: 'Returning Value in a Challenging Time' 17Health News:Nihon LocalSoft Designs New Japanese Software for IRadimed Corporation's Award-Winning MRidium MRI Infusion System 2
    Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
    Kit is supplied with four secondary bars. Secondary bars attach to primary bar. Length 12 (305 mm)....
    TEW serrated micro-retractor blade set....
    Mini-Vise....
    Medicine Products: